https://pubmed.ncbi.nlm.nih.gov/32244252/
Although no therapies are approved for light chain (AL) amyloidosis, cyclophosphamide, bortezomib, and dexamethasone (CyBorD) is considered standard of care....
newly diagnosedal amyloidosisdaratumumabpluscybord
https://www.mskcc.org/news/car-cell-therapy-for-light-chain-al-amyloidosis-achieves-strong-results
Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis.
cell therapylight chainal amyloidosiscar